Atrial Fibrillation Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with atrial fibrillation (an irregular heartbeat condition) and have a stroke risk score above 1 based on a standard medical scoring system called CHA2DS2-VASc (confirm with trial site)
Who may not be able to join:
- People who are unwilling or unable to give their written agreement to take part in the study
- People who have had a serious heart attack (acute coronary syndrome) within the 12 months before joining
- People with very severe heart failure (classified as the most serious stage, known as NYHA Class IV)
- People who have had a stroke within the 6 months before joining
- People with severe liver disease or severe muscle disease
- People with severe kidney disease or kidney failure, where a specific kidney function measurement (creatinine) is above a certain level
- People where it would not be possible to contact them or a family member for a follow-up check one year after the study procedure
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Elizaveta Panchenko, PhD, National Medical Research Center for Cardiology, Ministry of Health of Russian Federation
Phone: +79166760695
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
composite of major cardiovascular events; composite of any bleeding events
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.